GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N92020C00033UBIQUITOME LIMITED

Overview

Award facts

Net obligations
$1.46M
$1,462,373of $1.46M potential value
Outlays (paid to date)
$1.46M
$1.46M paid of $1.46M obligated$1,462,373
Period of performance
Sep 29, 2020 to Apr 16, 2021
Ended
Modifications
2
Latest action Nov 30, 2021
Contract type
Definitive contract
PIID 75N92020C00033

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

RADX TECH PROJECT #4554: UBIQUITOME SARS-COV-2 LAB TEST ACCURACY WITHIN REACH OF EVERY AMERICAN WITH LIBERTY16 MOBILE REAL TIME PCR

Dates and value

Award date
Signed on Sep 29, 2020
Potential end of performance
Apr 29, 2021
Current value
$1,462,373Base and exercised options
Potential value (if all options are exercised)
$1,462,373

Obligations by fiscal year of action

  • FY2022: -$997,627 (de-obligation)
  • FY2021: $1,760,000
  • FY2020: $700,000

Total across 3 fiscal years: $1,462,373

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 30, 2021. View on USAspending · Recipient on SAM.gov

Recipient

LocationAUCKLAND, NZL
UEIDGS8FJVKUM33
CAGE codeEBNE8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyUBIQUITOME LIMITED

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NHLBI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIBIB
Funded from
Public health and social services emergency fund; National institute of biomedical imaging and bioengineering (0898)Program activities075-0140, 075-0898Federal accounts (agency financial reports)

Place of performance

Place of performance
New Zealand

Classification and competition

Classification

Competition

Extent competed
Not available for competitionB
Reason not competed
Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Major program
Rapid acceleration of diagnostics (RADX)
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial itemA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 29, 2020Base obligation at award: $700,000
Latest action
Nov 30, 2021 — Terminated for convenienceModification P00002; obligation change -$997,627
Latest substantive action
Nov 30, 2021 — Terminated for convenienceModification P00002; obligation change -$997,627
Actions by type
  • Base award1
  • Terminated for convenience1
  • Letter contract definitized1
3 actions recorded, Sep 29, 2020 to Nov 30, 2021; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$997,627
Latest action: change in base and all options
-$997,627

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
National interest action
COVID-19 2020P20C
Contingency, humanitarian or peacekeeping operation
Presidential issued emergency declaration, or a major disaster declarationC

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
New zealandNZL
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N920
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N92D
Treasury accounts
  • 075-X-0140-000
  • 075-X-0898-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • P: Emergency P.L. 116-139
COVID-19 supplemental obligations
$1,462,373
COVID-19 supplemental outlays
$1,462,373